ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine

ClinicalTrials.gov ID: NCT03855137

Public ClinicalTrials.gov record NCT03855137. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine (Progress)

Study identification

NCT ID
NCT03855137
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allergan
Industry
Enrollment
778 participants

Conditions and interventions

Interventions

  • Atogepant 30 mg Drug
  • Atogepant 60 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 10, 2019
Primary completion
Jan 19, 2022
Completion
Jan 19, 2022
Last update posted
Feb 13, 2023

2019 – 2022

United States locations

U.S. sites
41
U.S. states
25
U.S. cities
38
Facility City State ZIP Site status
Barrow Neuro Institute /ID# 236776 Phoenix Arizona 85013
Baptist Health Center for Clinical Research /ID# 237361 Little Rock Arkansas 72205
California Headache and Balance Center /ID# 236246 Fresno California 93720
Wr-Pri Llc /Id# 236008 Los Alamitos California 90720
Pharmacology Research Institute (PRI) - Newport Beach (Wake) /ID# 237692 Newport Beach California 92660
Schuster Medical Research Institute /ID# 236447 Sherman Oaks California 91403
Alpine Clinical Research Center /ID# 234346 Boulder Colorado 80301-1880
George Washington University Medical Faculty Associates /ID# 238011 Washington D.C. District of Columbia 20037-3201
Accel Research Sites - St Petersburg Clinical Research Unit /ID# 237161 St. Petersburg Florida 33709-3113
Accel Research Sites - Tampa Clinical Research Unit /ID# 237485 Tampa Florida 33634
Premiere Research Institute - Palm Beach /ID# 238192 West Palm Beach Florida 33407-3209
NeuroTrials Research Inc. /ID# 237364 Atlanta Georgia 30328
Josephson-Wallack-Munshower Neurology - NE /ID# 238234 Indianapolis Indiana 46256-4692
Collective Medical Research /ID# 236400 Prairie Village Kansas 66208
Ochsner Clinic Foundation /ID# 236543 Covington Louisiana 70433-8107
Beth Israel Deaconess Medical Center /ID# 237540 Boston Massachusetts 02215-5400
BTC of New Bedford /ID# 236384 New Bedford Massachusetts 02740
Clinical Research Institute, Inc /ID# 238299 Minneapolis Minnesota 55402-2606
Headache Neurology Research Institute /ID# 236464 Ridgeland Mississippi 39157
Nevada Headache Institute /ID# 236420 Las Vegas Nevada 89113
Dartmouth-Hitchcock Medical Center /ID# 237444 Lebanon New Hampshire 03756
Albuquerque Clinical Trials, Inc /ID# 236853 Albuquerque New Mexico 87102
Albany Medical Center Rheumatology /ID# 236540 Albany New York 12208-3412
Dent Neurosciences Research Center, Inc. /ID# 237040 Amherst New York 14226
Headache Wellness Center /ID# 236431 Greensboro North Carolina 27405
Raleigh Neurology Associates /ID# 237141 Raleigh North Carolina 27607
Stetson-University of Cincinnati /ID# 236453 Cincinnati Ohio 45219
Abington Neurological Associates - Abington /ID# 236258 Abington Pennsylvania 19001
Preferred Primary Care Physicians, Inc. /ID# 236439 Pittsburgh Pennsylvania 15236
WR-ClinSearch /ID# 238288 Chattanooga Tennessee 37421-1605
Clinical Neuroscience Solutions - Memphis /ID# 237478 Memphis Tennessee 38119
DiscoveResearch, Inc /ID# 236274 Bryan Texas 77802
Texas Neurology /ID# 236359 Dallas Texas 75214
University of Texas Southwestern Medical Center /ID# 236941 Dallas Texas 75390-7208
J. Lewis Research, Inc. / Foothill Family Clinic /ID# 236395 Salt Lake City Utah 84109
J. Lewis Research, Inc. Foothill Family Clinic South /ID# 236297 Salt Lake City Utah 84121
Highland Clinical Research /ID# 237816 Salt Lake City Utah 84124
MedStar Georgetown Neurology /ID# 236324 McLean Virginia 22101
Sentara Neurology Specialists - Virginia Beach /ID# 234349 Virginia Beach Virginia 23456-0019
Northwest Clinical Research Center /ID# 237581 Bellevue Washington 98007
Puget Sound Neurology /ID# 236321 Tacoma Washington 25328

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03855137, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 13, 2023 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03855137 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →